Mouse study links cannabis compound NCT to gut-barrier and immune effects
N-Trans Caffeoyltyramine Alleviates Ulcerative Colitis by Targeting FXR to Promote Epithelial Barrier Protection and M2 Macrophage Polarization.
AI Summary
This study asked whether two compounds found in Cannabis sativa—N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT)—could ease ulcerative colitis. Researchers compared them in a mouse model of acute colitis and examined their effects in colonic epithelial cells and macrophages. The abstract reports that NCT was more effective than NFT at alleviating acute colitis in the mice.
The proposed explanation is that NCT helps preserve the intestinal lining by increasing tight junction proteins and promotes a protective M2 macrophage state. The nuclear receptor FXR contributed to both effects in genetic loss-of-function experiments. These are preclinical findings: the abstract does not establish that NCT treats ulcerative colitis in people, and it gives no quantitative results. This is an abstract-based summary; the findings support further preclinical study, not a clinical treatment conclusion.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Inflammation research papers you might find interesting.
In septic rats, lenabasum reduced lung injury markers over 24 hours
Endocannabinoid levels differed in RA and tracked disease activity in women
Lab tests found resin effects depended more on microbes and concentration
Explore More Research
Stay informed about the latest cannabis science.